Yondelis 1 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9W53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,938
Award facts
- Contract value 100% obligated
- $14,938.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,938.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for one milligram vials of Yondelis, a chemotherapy medication used in cancer treatment. This contract, issued on January 12, 2026, with an ultimate completion date of February 3, 2026, was not set aside for small business or other designated groups, indicating open and full competition. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its principal operations as a major pharmaceutical distributor and healthcare solutions provider.
This delivery order was issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical division through December 31, 2031. This comprehensive IDC vehicle enables Cencora to supply a broad range of pharmaceutical products, medical supplies, specialty medications, and medical devices to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The underlying IDC structure allows for flexible procurement of critical oncology and specialty pharmaceutical commodities across multiple therapeutic domains to meet federal military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F9W53?
SPE2DR26F9W53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9W53 worth?
The government has obligated $14,938 on SPE2DR26F9W53.
Is contract SPE2DR26F9W53 an order under another contract?
Yes. SPE2DR26F9W53 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W53 competed?
The extent of competition for SPE2DR26F9W53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award